Geri
PreveCeutical Medical Inc. (PRVCF) Fiyatı
PRVCF Hisse Senedi Fiyat Grafiği
PRVCF Kazanmak
PreveCeutical Medical Inc.
$0.01
0%
$0
Kapanışta: Jan 21, 16:00:00 GMT-5
$0.01
0%
$0
Sonrası Piyasa: Jan 21, 20:00:00 GMT-5
Earnings FAQ
PRVCF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
PreveCeutical Medical Inc. PRVCF'ün son çeyrekteki geliri nasıl performans gösterdi?
PreveCeutical Medical Inc.'in gelir tahmini nedir?
PreveCeutical Medical Inc.'in kazanç kalite puanı nedir?
PreveCeutical Medical Inc. kazançlarını ne zaman rapor eder?
PreveCeutical Medical Inc.'in beklenen kazançları nelerdir?
PreveCeutical Medical Inc. kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.0156
Açılış fiyatı
$0.0181
Günün Aralığı
$0.0156 - $0.0181
52 haftalık aralık
$0.0037 - $0.0436
İşlem hacmi
26.2K
Ort.Hacim
59.4K
EPS (TTM)
0.00
Dividend yield
--
Piyasa Değeri
$9.1M
PreveCeutical Medical Inc. nedir?
Preveceutical Medical Inc is a CA-based company operating in industry. The company is headquartered in West Vancouver, British Columbia. The company went IPO on 2016-12-30. PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, and BSV Peptide Program. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). Its Nature Identical peptides used for treatment of various ailments. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved